Form 4 for AURA Aura Biosciences, Inc.
Accepted 2021-10-29 00:00:00 ET · period of report 2021-10-28 · accession 0000899243-21-042090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-29 | 2021-10-28 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | $0.00 | +74.4K | 74.4K | New | $0 |
| D | 2021-10-29 | 2021-10-28 | AURA | de los Pinos Elisabet | See Remarks, Dir | A - Grant | — | +318.8K | 318.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-28 | A | A | 74,357 | $0.00 | 74,357 | D | — | — | (F1) These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-10-28 | A | A | 318,750 | — | 318,750 | D | $14.00 · — to 2031-10-27 | 318,750 Common stock | (F3) The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments. |